Abstract
Introduction: Infertility is one of the factors which have a significant effect on the sexual performance of couples, especially women. Infertility can affect sexual activity in infertile couples. On the other hand, ovulation stimulation therapies for infertility treatment can inhibit estrogen and thus reduce women's sexual function and satisfaction. Therefore, this study was performed with aim to determine and compare the sexual performance and satisfaction of women treated with two types of ovulation stimulant drugs: clomiphene and letrozole. Methods: This two-group analytical study was performed on 80 infertile women referred to infertility centers in Isfahan province in 2019. The research tools were the questionnaires of Beck, sexual function and sexual satisfaction, which were completed twice before and after receiving clomiphene and letrozole. Data were analyzed by SPSS software (version 22) and Independent t-test, Mann-Whitney, Chi-square, Paired t-test, Wilcoxon and Friedman tests. P<0.05 was considered statistically significant. Results: In intra-group comparison, there was no statistically significant difference before and after drug administration in the variables of sexual satisfaction (p=0.053) and sexual function (p=0.057), but in inter-group comparison, there was a statistically significant difference in sexual function of the clomiphene group (P 0.05). There was no significant difference in letrozole group before and after drug administration in both variables of sexual function and satisfaction (p=0.053). Conclusion: The score of sexual performance decreased in the clomiphene group, but sexual satisfaction did not show any difference in any of the groups. In other words, women's sexual function is affected by many factors, one of which is the use of assisted reproductive drugs, including clomiphene. Clomiphene inhibits vaginal moisture by inhibiting estrogen, which can cause pain and reduce sexual arousal, orgasm, and libido in women. For this purpose, it is recommended that active people in the field of infertility pay attention to this issue.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Iranian Journal of Obstetrics, Gynecology and Infertility
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.